Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
A new investment is aimed at boosting advanced manufacturing capacity for medicines produced in the Cincinnati area, according to a report citing Resilience and Eli Lilly.
THE APEX TIMES
THE APEX TIMES
The company said the investment is expected to add at least 400 jobs and raise employment at its Resilience site in the state to more than 1,400, according to a report carried by Yahoo Finance.
THE APEX TIMES
An analyst’s underlying fair-value target for UnitedHealth Group moved higher following the company’s Q2 results, a shift that the market interpreted as an improvement in expectations.
THE APEX TIMES
A fresh cluster of European Commission approvals this week adds to the region’s evolving drug landscape, including updates affecting Pfizer’s and BioNTech’s vaccine portfolio and Incyte’s skin cancer and inflammatory pipeline.
THE APEX TIMES
The Woonsocket, Rhode Island-based health insurer and pharmacy retailer says its customer experience performance was recognized with an overall top honor plus four separate Gold Awards at the 2026 U.S. Customer Experience Awards.
THE APEX TIMES
A new Yahoo Finance look at Pfizer’s upcoming results for the quarter ended June 2026 urges investors to judge the quarter using more than analysts’ expected earnings and revenue figures.
THE APEX TIMES
The pact positions the drugmaker as a “foundational participant” in Illumina’s Billion Cell Atlas effort to build a large genome-wide genetic perturbation dataset, a resource intended to help train and validate AI approaches for identifying potential medicines.
THE APEX TIMES
The biotech is scheduled to release its quarterly earnings before market hours, with investors watching for updates on the company’s programs and financial outlook.
THE APEX TIMES
The letter, circulated via download through an investor commentary published on Yahoo Finance, frames UnitedHealth Group as a long-term holding, with emphasis on compounding and disciplined valuation.
